Randomized double‐blind placebo‐controlled study to evaluate the effect of long‐acting mesalamine on postinfectious irritable bowel syndrome with diarrhea
In patients with PI-IBS, long-acting mesalamine demonstrated to be effective in reducing IBS symptoms and improving QOL.
Authors
- Daniel T. Leung (ORCID: https://orcid.org/0000-0001-8401-0801)
- Nicholas. J. Talley (ORCID: https://orcid.org/0000-0001-5586-8606)
- Ashok K. Tuteja (ORCID: https://orcid.org/0000-0002-4509-1976)
- John C. Fang (ORCID: https://orcid.org/0000-0003-3274-3979)
- Gregory J. Stoddard (ORCID: https://orcid.org/0000-0002-6292-276X)
Institutions
- University of Utah (US)
- University of Newcastle Australia (AU)
Publication Details
- Journal
- Neurogastroenterology & Motility
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1111/nmo.14889
- Citations
- 3
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- U.S. Department of Defense
- U.S. Department of Veterans Affairs
- Shire